151 related articles for article (PubMed ID: 30404721)
1. Disparities in the allocation of research funding to gynecologic cancers by Funding to Lethality scores.
Spencer RJ; Rice LW; Ye C; Woo K; Uppal S
Gynecol Oncol; 2019 Jan; 152(1):106-111. PubMed ID: 30404721
[TBL] [Abstract][Full Text] [Related]
2. Large Publication Gap for Gynecologic Cancers in High-Impact Factor Journals.
Sinha N; McDonald A; Barry D; Barber EL
Obstet Gynecol; 2023 Sep; 142(3):467-475. PubMed ID: 37535969
[TBL] [Abstract][Full Text] [Related]
3. A Comparative Analysis of Survival and Funding Discrepancies in Cancers With High Mortality.
Hall BR; Cannon A; Atri P; Wichman CS; Smith LM; Kumar S; Batra SK; Wang H; Ganti AK; Sasson AR; Are C
Ann Surg; 2020 Feb; 271(2):296-302. PubMed ID: 30188400
[TBL] [Abstract][Full Text] [Related]
4. Urgent need to mitigate disparities in federal funding for cancer research.
Haghighat S; Jiang C; El-Rifai W; Zaika A; Goldberg DS; Kumar S
J Natl Cancer Inst; 2023 Oct; 115(10):1220-1223. PubMed ID: 37287319
[TBL] [Abstract][Full Text] [Related]
5. Impact of racial disparities on potential years of life lost due to gynecologic cancer in the United States: Trends from 1975 to 2017 based on SEER database.
Kaur A; Wang S; Kumar A
Gynecol Oncol; 2023 Mar; 170():266-272. PubMed ID: 36738485
[TBL] [Abstract][Full Text] [Related]
6. Survival Disparities by Hospital Volume Among American Women With Gynecologic Cancers.
Seagle BL; Strohl AE; Dandapani M; Nieves-Neira W; Shahabi S
JCO Clin Cancer Inform; 2017 Nov; 1():1-15. PubMed ID: 30657373
[TBL] [Abstract][Full Text] [Related]
7. Mortality rates due to gynecologic cancers in New York state by demographic factors and proximity to a Gynecologic Oncology Group member treatment center: 1979-2001.
Tan W; Stehman FB; Carter RL
Gynecol Oncol; 2009 Aug; 114(2):346-52. PubMed ID: 19411096
[TBL] [Abstract][Full Text] [Related]
8. Update of HPV-associated female genital cancers in the United States, 1999-2004.
Watson M; Saraiya M; Wu X
J Womens Health (Larchmt); 2009 Nov; 18(11):1731-8. PubMed ID: 19951205
[TBL] [Abstract][Full Text] [Related]
9. Disparities in National Cancer Institute and Nonprofit Organization Funding Disproportionately Affect Cancers With Higher Incidence Among Black Patients and Higher Mortality Rates.
Kamath SD; Chen Y
JCO Oncol Pract; 2024 Mar; 20(3):378-385. PubMed ID: 38190584
[TBL] [Abstract][Full Text] [Related]
10. Relationship between preexisting mental disorders and prognosis of gynecologic cancers: A case-control study.
Tamauchi S; Kajiyama H; Moriyama Y; Yoshihara M; Ikeda Y; Yoshikawa N; Nishino K; Niimi K; Suzuki S; Kikkawa F
J Obstet Gynaecol Res; 2019 Oct; 45(10):2082-2087. PubMed ID: 31321830
[TBL] [Abstract][Full Text] [Related]
11. Optimum screening interventions for gynecologic malignancies.
Lea JS; Miller DS
Tex Med; 2001 Feb; 97(2):49-55. PubMed ID: 11233059
[TBL] [Abstract][Full Text] [Related]
12. Trends in Place of Death Among Patients With Gynecologic Cancer in the United States.
Hicks-Courant K; Melamed A; Worley MJ; Kim YB; Schorge JO; Rauh-Hain JA
Obstet Gynecol; 2018 Jun; 131(6):1111-1120. PubMed ID: 29742673
[TBL] [Abstract][Full Text] [Related]
13. Profile of gynecologic malignancies reported at a tertiary care center in India over the past decade: comparative evaluation with international data.
Agarwal S; Malhotra KP; Sinha S; Rajaram S
Indian J Cancer; 2012; 49(3):298-302. PubMed ID: 23238148
[TBL] [Abstract][Full Text] [Related]
14. Trends in gynecologic cancer among elderly women in Denmark, 1980-2012.
Ør Knudsen A; Schledermann D; Nyvang GB; Mogensen O; Herrstedt J;
Acta Oncol; 2016; 55 Suppl 1():65-73. PubMed ID: 26784001
[TBL] [Abstract][Full Text] [Related]
15. End results, interhospital differences, and trends in patterns of care for gynecologic cancer.
Mettlin C
Cancer; 1987 Oct; 60(8 Suppl):1965-9. PubMed ID: 3652021
[TBL] [Abstract][Full Text] [Related]
16. Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial.
Anderson GL; Judd HL; Kaunitz AM; Barad DH; Beresford SA; Pettinger M; Liu J; McNeeley SG; Lopez AM;
JAMA; 2003 Oct; 290(13):1739-48. PubMed ID: 14519708
[TBL] [Abstract][Full Text] [Related]
17. Scope and Epidemiology of Gynecologic Cancers: An Overview.
Ledford LRC; Lockwood S
Semin Oncol Nurs; 2019 Apr; 35(2):147-150. PubMed ID: 30902519
[TBL] [Abstract][Full Text] [Related]
18. Exploring disparities in incidence and mortality rates of breast and gynecologic cancers according to the Human Development Index in the Pan-American region.
Martínez-Mesa J; Werutsky G; Michiels S; Pereira Filho CAS; Dueñas-González A; Zarba JJ; Mano M; Villarreal-Garza C; Gómez H; Barrios CH
Public Health; 2017 Aug; 149():81-88. PubMed ID: 28577441
[TBL] [Abstract][Full Text] [Related]
19. Gynecologic malignancies in women aged less than 25 years.
You W; Dainty LA; Rose GS; Krivak T; McHale MT; Olsen CH; Elkas JC
Obstet Gynecol; 2005 Jun; 105(6):1405-9. PubMed ID: 15932836
[TBL] [Abstract][Full Text] [Related]
20. Personalized Circulating Tumor DNA Biomarkers Dynamically Predict Treatment Response and Survival In Gynecologic Cancers.
Pereira E; Camacho-Vanegas O; Anand S; Sebra R; Catalina Camacho S; Garnar-Wortzel L; Nair N; Moshier E; Wooten M; Uzilov A; Chen R; Prasad-Hayes M; Zakashansky K; Beddoe AM; Schadt E; Dottino P; Martignetti JA
PLoS One; 2015; 10(12):e0145754. PubMed ID: 26717006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
